Korean J Urol.
1974 Sep;15(3):173-183.
Clinical Experiences with Hemodialysis for Renal Failure Using Kill Type Artificial Kidney
- Affiliations
-
- 1Department of Urology, College of Medicine, Seoul National University, Seoul, Korea.
Abstract
-
Hemodialysis using Kiil type artificial kidney was performed on 14 cases on renal failure and the following results were obtained: 1. Of 11 patients accepted for a combined hemodialysis-transplantation program, 4 underwent renal homotransplantation and 7 were maintained by intermittent hemodialysis. (total No. of hemodialysis; 181) * pre-op. average period of treatment; 38 days, average No. of hemodialysis; 4.8, average hours of HD/week; 7.1 2. Of 7 patients, who received long-term intermittent hemodialysis, 5 patients were died. * average period of treatment; 105 days, average No. of hemodialysis; 2l.4, average hours of HD/week; 12,2, combined diseases; long-standing hypertension, congestive heart failure, diabetes mellitus, and pericarditis. 3. Hemodialysis was undertaken in 3 patients under the diagnosis of acute renal failure. They were completely recovered. * average period of treatment; 27. 3 days, average No. of Hemodialysis, 5. average hours of hemodialysis; 41.3 4. Average loss of body weight by hemodialysis was 1.6kg. 5. For the group, who received long-term intermittent hemodialysis,. blood urea concentrations averaged 91 mg% before and 44 mg% after dialysis. Corresponding serum creatinine values were 12. 4 and 6.8mg% respectively. Thus, on the average, blood urea was reduced to 48.3% and serum creatinine to 54.8% of predialysis values by hemodialysis. 6. Patients on a program of long-term intermittent hemodialysis continued to require frequent transfusions. Average transfusion requirements was 178 ml. packed RBC per week. 7. Fifteen times operations for A.V cannulation were performed, by the same urologist in an operating room with patient under local anesthesia, in 10 patients, Complications were bleeding, infection and clotting in order. 8. Complications during hemodialysis were nausea, vomiting(8.O%), headache(5.6%). chilling (5.6%). hypotension(1.9%), bleeding(5.6%), clotting in dialyzer (1.9%), cannula-dialyzer line seperation(1.9%), and membrane leakage(1.2%) etc. My experiences have reinforced the impression that selection of patients are essential prerequisites for successful adaptation to long-term, intermittent hemodialysis therapy.